The Danish crown weakened on Friday, after disappointing results from a late-stage trial of a new weight-loss drug drove a big fall in the shares of Denmark's largest company, Novo Nordisk.
The logo of Danish pharmaceutical company Novo Nordisk is pictured at their headquarters in Bagsvaerd outside of Copenhagen, Denmark on February 1, 2017. Novo Nordisk (NVO) released mixed clinical ...
Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an expanded agreement to discover and develop novel treatments for obesity, ty ...
J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...